BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25938486)

  • 1. The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].
    De Rosa FG; Corcione S; Filippini C; Raviolo S; Fossati L; Montrucchio C; Aldieri C; Petrolo A; Cavallo R; Di Perri G
    PLoS One; 2015; 10(5):e0125149. PubMed ID: 25938486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy.
    Tedeschi S; Tumietto F; Giannella M; Bartoletti M; Cristini F; Cioni G; Ambretti S; Carretto E; Sambri V; Sarti M; Viale P;
    Eur J Intern Med; 2016 Oct; 34():39-44. PubMed ID: 27553696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis.
    Lin KY; Chen PY; Chuang YC; Wang JT; Sun HY; Sheng WH; Chen YC; Chang SC
    J Infect; 2018 Sep; 77(3):242-248. PubMed ID: 29932963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.
    López-Cortés LE; Almirante B; Cuenca-Estrella M; Garnacho-Montero J; Padilla B; Puig-Asensio M; Ruiz-Camps I; Rodríguez-Baño J;
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e1-8. PubMed ID: 27189197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting.
    Wade RL; Chaudhari P; Campbell RS; Hays HD; Nathanson BH; Yi J; Horn D
    J Med Econ; 2012; 15(6):1130-8. PubMed ID: 22788668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of biofilm production by Candida species and antifungal therapy on mortality of patients with candidemia.
    Lee CH; Chen YC; Chen IL; Chen FJ; Chien CC
    Mycoses; 2020 Dec; 63(12):1382-1391. PubMed ID: 32910518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
    Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis.
    Cuervo G; Garcia-Vidal C; Puig-Asensio M; Vena A; Meije Y; Fernández-Ruiz M; González-Barberá E; Blanco-Vidal MJ; Manzur A; Cardozo C; Gudiol C; Montejo JM; Pemán J; Ayats J; Aguado JM; Muñoz P; Marco F; Almirante B; Carratalà J;
    Clin Infect Dis; 2017 May; 64(10):1374-1379. PubMed ID: 28329281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.
    Garnacho-Montero J; Díaz-Martín A; Cantón-Bulnes L; Ramírez P; Sierra R; Arias-Verdú D; Rodríguez-Delgado M; Loza-Vázquez A; Rodriguez-Gomez J; Gordón M; Estella Á; García-Garmendia JL
    Crit Care Med; 2018 Mar; 46(3):384-393. PubMed ID: 29189345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of empirical treatment with antifungal agents on survival of patients with candidemia.
    Poves-Alvarez R; Cano-Hernández B; Muñoz-Moreno MF; Balbás-Alvarez S; Román-García P; Gómez-Sánchez E; Martínez-Rafael B; Gómez-Pesquera E; Lorenzo-López M; Alvarez-Fuente E; de la Varga O; Flores M; Eiros JM; Tamayo E; Heredia-Rodríguez M
    Rev Esp Quimioter; 2019 Feb; 32(1):6-14. PubMed ID: 30499639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis.
    Bienvenu AL; Pradat P; Guerin C; Aubrun F; Fellahi JL; Friggeri A; Guichon C; Hernu R; Menotti J; Monard C; Paulus S; Rimmele T; Piriou V; Chidiac C; Argaud L; Leboucher G
    Int J Infect Dis; 2020 Apr; 93():15-21. PubMed ID: 31982622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence, presentation and treatment of candidemia.
    Mikulska M; Del Bono V; Ratto S; Viscoli C
    Expert Rev Clin Immunol; 2012 Nov; 8(8):755-65. PubMed ID: 23167687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.
    Eschenauer GA; Nguyen MH; Clancy CJ
    Ann Pharmacother; 2015 Sep; 49(9):1068-74. PubMed ID: 26104051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia in non-ICU surgical wards: Comparison with medical wards.
    Vena A; Bouza E; Valerio M; Padilla B; Paño-Pardo JR; Fernández-Ruiz M; Díaz Martín A; Salavert M; Mularoni A; Puig-Asensio M; Muñoz P;
    PLoS One; 2017; 12(10):e0185339. PubMed ID: 29045423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and therapeutic aspects of candidemia: a five year single centre study.
    Bassetti M; Merelli M; Ansaldi F; de Florentiis D; Sartor A; Scarparo C; Callegari A; Righi E
    PLoS One; 2015; 10(5):e0127534. PubMed ID: 26010361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.
    Heimann SM; Cornely OA; Wisplinghoff H; Kochanek M; Stippel D; Padosch SA; Langebartels G; Reuter H; Reiner M; Vierzig A; Seifert H; Vehreschild MJ; Glossmann J; Franke B; Vehreschild JJ
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):331-8. PubMed ID: 25213718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
    Falcone M; Russo A; De Rosa FG; Pasero D; Toma L; Raponi G; Ghezzi MC; Venditti M
    J Chemother; 2010 Dec; 22(6):397-401. PubMed ID: 21303747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
    Tagliaferri E; Menichetti F
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.